Edgewise Therapeutics Announces Positive Sevasemten Results for Becker and Duchenne Muscular Dystrophy
Edgewise Therapeutics reported positive results from its sevasemten program for Becker and Duchenne muscular dystrophies. In Becker MD, open-label da...